Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20042
20052
20065
20072
20083
20094
20106
20112
20121
20131
20141
20161
20181
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated7
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
The Medicines Company4
AstraZeneca3
DalCor Pharmaceuticals2
Eli Lilly and Company2
GlaxoSmithKline2
Abbott Diagnostics Division1
Amarin Pharma Inc.1
Angel Medical Systems1
Anthera Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome39
Myocardial Infarction17
Angina, Unstable8
Coronary Artery Disease8
Cardiovascular Diseases6
Atherosclerosis5
Heart Diseases5
Myocardial Ischemia5
Coronary Disease3
Non-ST Elevated Myocardial Infarction3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.